期刊文献+

丙酸氟替卡松治疗儿童过敏性鼻炎的效果分析 被引量:3

Efficacy of fluticasone propionate in the treatment of children with allergic rhinitis
下载PDF
导出
摘要 目的探讨丙酸氟替卡松治疗儿童过敏性鼻炎的效果及机制。方法选择2015年3月至2016年3月该院接诊的儿童过敏性鼻炎患儿120例为研究对象,随机将其分为观察组和对照组,每组60例。观察组的患儿采用丙酸氟替卡松气雾剂治疗,对照组的患儿采用酮替芬治疗。观察两组患儿的治疗效果以及治疗前后骨桥蛋白、白细胞介素(IL)-4、IL-5水平,并比较不良反应发生情况。结果经研究发现,观察组有效率93.3%,与对照组(85.0%)相比,差异有统计学意义(P<0.05)。观察组骨桥蛋白、IL-4、IL-5的水平在丙酸氟替卡松气雾剂治疗前后比较,差异有统计学意义(P<0.05)。观察组和对照组的不良反应发生率分别为5.0%和6.7%,差异无统计学意义(P>0.05)。结论丙酸氟替卡松可以改善过敏性鼻炎患儿的症状,治疗效果较好,能明显提高患儿的生活质量,值得进一步研究应用。 Objective To investigate the effects of fluticasone propionate and inflammatory mechanism of children with allergic rhinitis.Methods A total of 120 children with allergic rhinitis in our hospital from March 2015 to March 2016 were selected and randomly divided into observation group and control group.Children in the observation group were treated with fluticasone propionate aerosol,and children in the control group were treated with ketotifen.The therapeutic effect of the two groups of patients and the levels of osteopontin,IL-4 and IL-5 before and after treatment were observed.And the incidences of adverse reactions were compared.Results The study found that the effective rates of observation group and control group were93.3% and 85.0%,the difference was statistically significant(P〈0.05).After treatment,the levels of osteopontin,IL-4 and IL-5 in the observation group were significantly lower than before(P〈0.05).The incidences of adverse reactions in the observation group and the control group were 5.0%and 6.7%,respectively,and there was no significant difference between the two groups(P〈0.05).Conclusion Fluticasone propionate could improve the symptom of children with allergic rhinitis,and has a better effect,as well as improve the quality of life of children.It is worthy of deeper research.
作者 陈锋 詹飞 CHEN Feng;ZHAN FeiA(Department of Pediatrics,Xiangyang Center Hospital Affiliated of Hubei Arts and Science College,Xiangyang,Hubei 441021,China)
出处 《检验医学与临床》 CAS 2018年第14期2126-2128,共3页 Laboratory Medicine and Clinic
关键词 过敏性鼻炎 丙酸氟替卡松 骨桥蛋白 白细胞介素 allergic rhinitis fluticasone propionate osteopontin interleukin
  • 相关文献

参考文献10

二级参考文献121

  • 1儿童哮喘诊断标准和治疗常规[J].中华儿童保健杂志,1993,1(4):249-251. 被引量:325
  • 2宋理君,虞积仁.T细胞亚群分布的测定及其临床意义[J].国外医学(临床生物化学与检验学分册),1989,10(4):1-3.12. 被引量:18
  • 3中华医学会耳鼻咽喉科学分会.变应性鼻炎诊断标准及疗效评定标准[J].中华耳鼻咽喉科杂志,1998,33(3):134-134.
  • 4张罗,韩德民.变应性鼻炎的变应原特异性皮下免疫治疗[J].中华耳鼻咽喉头颈外科杂志,2007,42(9):711-716. 被引量:26
  • 5COLLISON L W,WORKMAN C J,KUO T T,et al.The inhibitory cytokine IL-35contributes to regulatory T-cell function[J].Nature,2007,450:566-569.
  • 6NIEDBALA W,WEI X Q,CAI B,et al.IL-35is a novel cytokine with therapeutic effects against collageninduced arthritis through the expansion of regulatory T cells and suppression of Th17cells[J].Eur J Immunol,2007,37:3021-3029.
  • 7AGRAWAL D K,SHAO Z.Pathogenesis of allergic airway inflammation[J].Curr Allergy Asthma Rep,2010,10:39-48.
  • 8OZDEMIR C,AKDIS M,AKDIS C A.T regulatory cells and their counterparts:masters of immune regulation[J].Clin Exp Allergy,2009,39:626-639.
  • 9COLLISON L W.IL-35-mediated induction of a potent regulatory T cell population[J].Nat Immunol,2010,11:1093-1101.
  • 10COLLISON L W,PILLAI M R,CHATURVEDI V,et al.Regulatory T cell suppression is potentiated by target T cells in a cell contact,IL-35-and IL-10-dependent manner[J].J Immunol,2009,182:6121-6128.

共引文献267

同被引文献30

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部